Bevacizumab (BV) maintenance (M) after first-line chemotherapy (CT) plus BV for metastatic colorectal cancer (mCRC) patients (pts): A meta-analysis of individual pts data (IPD) from three phase III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback